Jade Biosciences (JBIO, $9.9) price may drop as it broke higher Bollinger Band on Oct 15, 2025
Tickeron - Stocks
Jade Biosciences (JBIO, $9.9) Aroon Indicator entered an Uptrend on October 15, 2025.
Tickeron - Stocks
Avidity Biosciences (RNA, $50.47) Aroon Indicator entered an Uptrend on October 15, 2025.
Tickeron - Stocks
Forte Biosciences (FBRX, $12.94) price may climb as it broke lower Bollinger Band on Oct 15, 2025
Tickeron - Stocks
Covenant Logistics Group (CVLG, $20.98) Moving Average Convergence Divergence (MACD) Histogram turned positive on October 15, 2025
Tickeron - Stocks
Kuros Bioscience (CSBTF, $39.04) RSI Indicator left the overbought zone on October 15, 2025
Tickeron - Stocks
Cogent Biosciences (COGT, $16.57) RSI Indicator left the overbought zone on October 15, 2025
Tickeron - Stocks
Solid Biosciences (SLDB, $6.32) Aroon Indicator entered an Uptrend on October 15, 2025.
Tickeron - Stocks
Sol-Gel Technologies (SLGL, $41.76) Aroon Indicator entered an Uptrend on October 15, 2025.
Tickeron - Stocks
Arcus Biosciences (RCUS, $16.9) Stochastic Oscillator left the overbought zone on October 15, 2025
Tickeron - Stocks
Arcus Biosciences (RCUS, $16.9) RSI Indicator left the overbought zone on October 15, 2025
Tickeron - Stocks
IDEAYA Biosciences (IDYA, $28.38) price may drop as it broke higher Bollinger Band on Oct 15, 2025
Tickeron - Stocks
IDEAYA Biosciences (IDYA, $28.38) Moving Average Convergence Divergence (MACD) Histogram turned positive on October 15, 2025
Tickeron - Stocks
Pacira BioSciences (PCRX, $23.45) RSI Indicator left the oversold zone on October 15, 2025
Tickeron - Stocks
FreightCar America (RAIL, $9.86) entered Uptrend as Momentum indicator ascends above 0 level on Oct 15, 2025
Tickeron - Stocks
Alamo Group (ALG, $184.03) RSI Indicator left the oversold zone on October 15, 2025
Tickeron - Stocks
TSMC 3Q25 earnings hit a record high with gross margin near 60%
DigiTimes: IT news from Asia
Nokia (NOK) to Release Earnings on Thursday
MarketBeat
Sweco Expands in Belgium with Acquisition of Assar Architects
TipRanks Financial Blog
Pulse Biosciences (PLSE): Evaluating Valuation as Revenue Growth Outpaces Sector but Profitability Remains Elusive
Simply Wall St
3 Reasons ALGN is Risky and 1 Stock to Buy Instead
StockStory Articles
